Skip to main content
. 2017 Nov 10;2017:6873281. doi: 10.1155/2017/6873281

Figure 6.

Figure 6

Effect of edaravone on alteplase-induced fibrinolysis in PPP. (a) Effects of alteplase (50, 100, or 250 IU/ml) in pooled platelet-poor plasma (n = 5). Error bars represent standard deviation. (b) Effects of edaravone (6 or 60 nM), alteplase (100 IU/ml), or their combination on alteplase-induced thrombolysis in pooled PPP (n = 5). Error bars represent standard deviation. (c) Measurement of D-dimer concentration to evaluate effects of edaravone (60 nM) on H2O2 (100 μM)-inhibited fibrinolysis by alteplase (100 IU/ml) in pooled PPP (n = 5). Error bars represent standard deviation. PPP: platelet-poor plasma; H2O2: hydrogen peroxide.